Health Condition 1: null- Hyperlipidemia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Age between 20 to 60 years Elevated levels of S. Cholesterol ( >200mg/dL) and/or Elevated S. Triglycerides ( >150mg/dL) and/or Elevated S.LDL ( >130mg/dL) and/or Elevated S. VLDL ( >40mg/dL)
Exclusion criteria
Exclusion criteria: Age less than 20 years and more than 60 years. Any concomitant serious disorders of liver, kidneys, heart, lung and other organs. Gravid women and lactating mothers. Persons undergoing treatment for any other serious illness.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected that the trial drugs will exert a significant action over lipids of different categories (cholesterol, triglyceride, LDL, VLDL, HDL)Timepoint: up to 8 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| By maintaining the healthy level of lipids, the drug will control conditions associated with hyperlipidemia like various cardiovascular diseases such as Atherosclerosis, Cardiac Arrest, Stroke, Heart Attack, etc.Timepoint: up to 8 weeks | — |
Countries
India
Contacts
I P G T and R A GAU Jamnagar